🔗 Share this article

This year's Nobel Prize in Physiology or Medicine was awarded for transformative findings that illuminate how the immune system targets dangerous pathogens while sparing the body's own cells.

Three esteemed scientists—Japan's Prof. Sakaguchi and US scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

The work identified specialized "security guards" within the immune system that remove malfunctioning immune cells capable of harming the organism.

The findings are now paving the way for new treatments for immune disorders and cancer.

These winners will divide a prize fund valued at 11m SEK.

Crucial Discoveries

"Their work has been essential for comprehending how the immune system functions and why we don't all suffer from severe autoimmune diseases," stated the chair of the Nobel Committee.

The team's research address a fundamental mystery: In what way does the immune system protect us from countless infections while keeping our healthy cells unharmed?

Our immune system employs immune cells that scan for indicators of infection, including pathogens and germs it has not met before.

These defenders utilize detectors—called receptors—that are generated randomly in a vast number of variations.

This provides the defense network the capacity to fight a broad range of threats, but the randomness of the mechanism unavoidably produces immune cells that may target the host.

Security Guards of the Body

Researchers earlier understood that a portion of these problematic white blood cells were destroyed in the thymus—the site where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "peacekeepers"—which travel through the system to neutralize any immune cells that assault the body's own tissues.

It is known that this mechanism fails in autoimmune diseases such as juvenile diabetes, MS, and RA.

The prize committee added, "The findings have established a novel area of research and accelerated the creation of new therapies, for example for tumors and autoimmune diseases."

Regarding malignancies, regulatory T-cells block the system from attacking the growth, so studies are aimed at lowering their numbers.

In autoimmune diseases, experiments are testing boosting regulatory T-cells so the body is no longer being harmed. A similar method could also be useful in minimizing the chances of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of Osaka University, conducted tests on rodents that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing immune cells from other mice could prevent the illness—suggesting there was a mechanism for blocking immune cells from attacking the body.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Fred Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic immune disorder in rodents and people that resulted in the discovery of a gene critical for the way T-regs function.

"The groundbreaking research has revealed how the body's defenses is controlled by regulatory T cells, stopping it from accidentally attacking the healthy cells," said a leading biological science specialist.

"This research is a remarkable example of how basic physiological study can have broad consequences for human health."